Access cutting-edge primary biliary cholangitis treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.
Access primary biliary cholangitis specialists in San Francisco at no cost
This study follows strict safety protocols and ethical guidelines
All study-related primary biliary cholangitis treatment provided free
To Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients with Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis.
Sponsor: Gilead Sciences
Check if you qualify for this primary biliary cholangitis clinical trial in San Francisco, CA
If you're searching for primary biliary cholangitis treatment options in San Francisco, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced primary biliary cholangitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.